news
UK biotech on “positive trajectory”, says BIA
Cutting-edge science and large international investment are driving growth in the UK’s biotech sector, the organisation’s new report reveals.
List view / Grid view
BioIndustry Association (BIA)
news
UK manufacturing and R&D to benefit from new £360m investment
A joint government and industry investment of £92 million intended to expand UK medicine manufacturing facilities, form part of a new £360 million funding package from the UK government.
news
Life sciences sector to receive £650 million funding
Funding to support the UK's life sciences manufacturing, skills and infrastructure has been announced as part of a £650m growth package.
news
2021 a record year for investment in UK biotech
New data from the BioIndustry Association (BIA) and Clarivate has shown an increase of 60 percent, to £4.5bn in UK biotech funding in 2021, which is largely the result of overseas investment.
news
DHSC supports continuity of medical supplies in a no-deal Brexit scenario
The Secretary of State for Health and Social Care is supporting the continuity of medical supplies if the UK is to leave the EU without a deal.
news
New initiative launched to boost Northern Ireland’s life science industry
The UK’s newest life sciences asset, Health Innovation Research Alliance Northern Ireland (HIRANI), has been launched at a BIO reception.
news
EMA to relocate to Amsterdam, the Netherlands
The EMA will relocate to Amsterdam in the Netherlands. The Agency now has just over 16 months to prepare for the move and take up its operations in Amsterdam on 30 March 2019 at the latest...
article
Pursuing great science with MedImmune
As part of EPR’s Women in Pharma series, Dr Jane Osbourn, Vice President of Research & Development, MedImmune, talks to Science Editor Dr Zara Kassam about the importance of breaking through self-imposed barriers…
news
UK bioscience companies form Rare Disease Industry Group
The BIA is committed ensuring patient access to treatments for rare and very rare conditions, sometimes referred to as orphan and ultra-orphan medicines...
news
Future has “never been brighter” for US biopharmaceuticals
PhRMA report highlights the healthy nature of the US biopharmaceuticals industry, which invests about $75bn annually in research and development and supports nearly 4.7m jobs across the country
news
Brexit Health Alliance welcomes collaborative EU relationship
Niall Dickson responds to the commitment by the secretaries of state to seek a collaborative relationship with the EU in medicines regulation and supply...
news
BIA report shows UK on track to be world’s third global biotech cluster
A new report released by the UK BioIndustry Association (BIA) shows that the UK maintained its strong leadership position in European biotech funding last year and has the strongest pipeline in Europe for future drug development.
news
Reactions to the EU Referendum
24 June 2016 | By Victoria White, Digital Content Producer
The BioIndustry Association and EFPIA have reacted to the news that Britain has voted to leave the European Union (EU)...
news
BIA leads international call to review US court decision
21 April 2016 | By The UK BioIndustry Association (BIA)
The UK BioIndustry Association has urged the US Supreme Court to review a decision of a lower court that could hinder the development of new diagnostics and medicines...
article
Our EU referendum poll: the results are in
31 March 2016 | By Victoria White, European Pharmaceutical Review
We asked readers of if they agreed with BIA that the UK pharmaceutical industries are stronger in the EU. The results of that poll are now in...
